A team of researchers has published results of experiments in patients with treatment-resistant depression that provides direct evidence of at least one important mechanism through which ketamine…
Read More
Even with the development and FDA approval in recent years of the first rapid-acting antidepressant medicines—to which more than 90 BBRF grants have contributed—the search for novel depression…
Read More
Researchers say they have identified an objective biomarker of recovery in major depression that in a small cohort of treatment-resistant patients was able (on an ongoing basis) to capture whether…
Read More
About 1.4% of U.S. adults (over 3 million people) experience Borderline Personality Disorder (BPD) in a typical year. But BPD is difficult to treat. Evidence for the effectiveness of medications…
Read More
In its first randomized, placebo-controlled test, an enhanced form of non-invasive brain stimulation called SNT (Stanford Neuromodulation Therapy, formerly called SAINT) generated "a large…
Read More
